Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients

International Journal of Laboratory Hematology

Volumn 30, Issue 1, 2008, Pages 11-16

  Kashef, S ^a,e   Karimi, M ^b   Amirghofran, Z ^c   Ayatollahi, M ^d   Pasalar, M ^b   Ghaedian, M M ^c   Kashef, M A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antiphospholipid antibodies; HCV infection; Thalassemia; Thrombosis

Indexed keywords

CARDIOLIPIN ANTIBODY; HEPATITIS C ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; BLOOD TRANSFUSION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SPLENECTOMY; STATISTICAL ANALYSIS; THALASSEMIA MAJOR; THROMBOEMBOLISM;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIPHOSPHOLIPID SYNDROME; BETA-THALASSEMIA; BLOOD TRANSFUSION; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IRAN; LUPUS COAGULATION INHIBITOR; MALE; PREVALENCE;

EID: 38049012991     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2007.00916.x     Document Type: Article

References (31)

1. Ansar M.M. Kooloobandi A. (2002) Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. Journal of Viral Hepatitis 9, 390 392.
2. Asherson R.A. Cervera R. (2003) Antiphospholipid antibodies and infections. Annals of the Rheumatic Diseases 62, 388 393.
3. Bertolaccini M.L., Khamashta M.A. Hughes G.R. (2005) Diagnosis of antiphospholipid syndrome. Nature Clinical Practice. Rheumatology 1, 40 46.
4. Brandt J.T., Triplett D.A., Alving B. Scharrer I. (1995) Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thrombosis and Haemostasis 74, 1185 1190.
5. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., Yamamoto A.M., Camproux A.C., Hausfater P., Musset L., Veyssier P., Raguin G. Piette J.C. (2000) Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 79, 47 56.
6. Cappellini M.D., Robbiolo L., Bottasso B.M., Coppola R., Fiorelli G. Mannucci A.P. (2000) Venous thromboembolism and hyper coagulability in splenectomized patients with thalassemia intermedia. British Journal of Haematology 111, 467 473.
7. Cappellini M.D., Grespi E., Cassinerio E., Bignamini D. Fiorelli G. (2005) Coagulation and splenectomy: an overview. Annals of the New York Academy of Sciences 1054, 317 324.
8. Dalekos G.N., Kistis K.G., Boumba D.S., Voulgari P., Zervou E.K., Drosos A.A. Tsianos E.V. (2000) Increased incidence of anticardiolipin antibodies in patients with hepatitis is not associated with aetiopathogenetic link to antiphospholipid syndrome. European Journal of Gastroenterology and Hepatology 12, 67 74.
9. Darnige L. (2006) Laboratory diagnosis of antiphospholipid syndrome. Revue de Medecine Interne 27, 296 301.
10. Eldor A., Durst R., Hy-Am E., Goldfarb A., Gillis S., Rachmilewitz E.A., Abramov A., MacLouf J., Godefray Y.C., De Raucourt E. Guillin M.C. (1999) Chronic hypercoagulable state in patients with beta-thalassemia major is already present in childhood. British Journal of Haematology 107, 739 746.
11. Gharavi A.E. Lockshin M.D. (1997) Antiphospholipid antibodies. In : Manual of Clinical Laboratory (eds N.R. Rose, E.C. Macario, J.D. Folds 5th edn, pp. 949 953. ASM press Immunology, Washington DC.
12. Gharavi A.E., Pierangeli S.S. Harris E.N. (2000) New developments in viral peptides and APL induction. Journal of Autoimmunity 15, 227 230.
13. Ghirardello A., Doria A., Ruffatti A., Rigoli A.M., Vesco P., Calligaro A. Gambari P.F. (1994) Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome? Annals of the Rheumatic Diseases 53, 140 142.
14. Giordano P., Galli M., Del Vecchio G.C., Altomare M., Norbis F., Ruggeri L., Petronelli M. De Mattia D. (1998) Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia. British Journal of Haematology 102, 903 906.
15. Jaiswal S.P., Chitnis D.S., Jain A.K., Inamdar S., Porwal A. Jain S.C. (2001) Prevalence of hepatitis viruses among multi-transfused homogenous thalassemia patients. Hepatology Research 19, 247 253.
16. Leroy V., Arvieux J., Jacob M.C., Maynard-Muet M., Baud M. Zarski J.P. (1998) Prevalence and significance of anticardiolipin, anti-β2 glycoprotein I and antiprothrombin antibodies in chronic hepatitis C. British Journal of Haematology 101, 468 474.
17. Levine J.S., Branch W. Rauch J. (2002) The antiphospholipid syndrome. New England Journal of Medicine 346, 738 746.
18. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force (1991) Guidelines on testing for the lupus anticoagulant. Journal of Clinical Pathology 44, 885 889.
19. McNeil H.P., Chesterman C.N. Krilis S.A. (1991) Immunology and clinical importance of antiphospholipid antibodies. Advances in Immunology 49, 193 280.
20. Michaeli J., Mittelman M., Grisara D. Rachmilewitz E.A. (1992) Thromboembolic complications in β-thalassemia major. Acta Haematologica 87, 71 74.
21. Moratelli S., De Sanctis V., Gemmati D., Serino M.L., Mari R., Gamberini M.R. Scapoli G.L. (1998) Thrombotic risk in thalassemic patients. Journal of Pediatric Endocrinology and Metabolism 11, 915 921.
22. Naithani R., Chandra J., Narayan S., Sharma S. Singh V. (2006) Thalassemia major - on the verge of bleeding or thrombosis? Hematology 11, 57 61.
23. Nsiri B., Ghazouani E., Gritli N., Mazigh C., Bayoudh F., Messaoud T., Fattoum S. Machghoul S. (1998) Antiphospholipid antibodies: lupus anticoagulants, anticaordiolipin and antiphospholipid isotypes in patients with sickle cell disease. Hematology and Cell Therapy 40, 107 112.
24. Pengo V., Biasiolo A., Pegoraro C., Cucchini U., Noventa F. Iliceto S. (2005) Antibody profiles for the diagnosis of antiphospholipid syndrome. Thrombosis and Haemostasis 93, 1147 1152.
25. Petrouas C., Vlachoyiannopoulos P., Kordossis T. Moutsopoulos H.M. (1999) Anti-phospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with α2-GPI. Journal of Autoimmunity 13, 347 355.
26. Pierangeli S.S., Gharavi A.E. Harris E.N. (2001) Testing for antiphospholipid antibodies: problems and solutions. Clinical Obstetrics and Gynecology 44, 48 57.
27. Roozbeh J., Serati A.R. Malekhoseini S.A. (2006) Arteriovenous fistula thrombosis in patients on regular hemodialysis: a report of 171 patients. Archives of Iranian Medicine 9, 26 32.
28. Sthoeger Z.M., Fogel M., Smirov A., Ergas D., Lurie Y., Bass D.D., Geltner D. Malnick S.D. (2000) Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection. Annals of the Rheumatic Diseases 59, 483 486.
29. Sumiyoshi A., Thakerngpol K. Sonakul D. (1992) Pulmonary micro thromboemboli in thalassemia cases. Southeast Asian Journal of Tropical Medicine and Public Health 23, 29 37.
30. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., Brey R., Derksen R., Harris E.N., Hughes G.R., Triplett D.A. Khamashta M.A. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis and Rheumatism 42, 1309 1311.
31. Zachou K., Liaskos C., Christodoulou D.K., Kardasi M., Papadamou G., Gatselis N., Georgiadou S.P., Tsianos E.V. Dalekos G.N. (2003) Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome. European Journal of Clinical Investigation 33, 161 168.